AZELEX
NDC 16110-869, azelaic acid, cream, from Almirall, LLC.
- Product NDC
- 16110-869
- Status
- Listed
- Labeler
- Almirall, LLC
- Dosage form
- CREAM
- Route
- CUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020428
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16110-869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELAIC ACID.2 g/g
Pharmacologic classes
Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16110-869-30 | 16110086930 | 1 TUBE in 1 CARTON (16110-869-30) / 30 g in 1 TUBE |
| 16110-869-50 | 16110086950 | 1 TUBE in 1 CARTON (16110-869-50) / 50 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75
Use it
Look up 16110-869 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16110-869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16110-869. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.